DryPowder
Find my investors
Investor listUpdated

12 Series B Biotech investors

As of October 22, 2026, DryPowder lists 12 Series B Biotech venture funds. Their median published check range is $250K–$3M (1 of 12 funds publish one). 1 has filed an SEC Form D in the last 90 days: DFJ Growth (Oct 19, 2026).

Free fund match

Which Series B Biotech funds are writing checks right now?

About 30 seconds. No signup or card needed. Ranked by thesis fit and check size.

funds listed
12
median check (1 of 12 publish one)
$250K–$3M
filed an SEC Form D in the last 90 days
1
last updated, 2026
Oct 22

Filed a Form D in the last 90 days

Each date links to its SEC EDGAR filing

All 12 Series B Biotech funds

  1. Speedinvest
    $250K–$3MSeedSeries ASeries BGrowth

    Speedinvest provides European startups with 'more expertise, connections, reach, and momentum' through specialist investment teams across six core…

    Partners not yet listed
  2. DFJ Growth
    San Mateo
    Series BSeries CGrowthFORM D

    Partner with visionary founders at the intersection of bold vision and relentless execution. Active investors seeking to be partners during the rapid…

    3 partners listed
  3. AME Cloud Ventures
    Palo Alto
    SeedSeries ASeries B

    Investing in entrepreneurs building infrastructure and value chains around data, from the full data stack (infrastructure to applications) with…

    Partners not yet listed
  4. AgFunder
    San Francisco
    SeedSeries ASeries B

    Investing in deeptech and foundational technologies that remove structural constraints to sustainable scale in food, agriculture, and planetary…

    Partners not yet listed
  5. Correlation Ventures
    San Francisco
    SeedSeries ASeries B

    Correlation Ventures backs groundbreaking technology and data science companies that solve industry problems through rapid decision-making and…

    Partners not yet listed
  6. Golden Ventures
    Toronto
    SeedSeries ASeries B

    Founder-driven investing focused on bold teams and transformative ideas. Hands-on approach informed by past lives as founders and operators.

    Partners not yet listed
  7. Dentsu Ventures
    Tokyo
    SeedSeries ASeries BSeries CGrowth

    Support domestic and international startups through capital provision and business collaboration, leveraging Dentsu Group's creative and strategic…

    Partners not yet listed
  8. Innovation Endeavors
    SeedSeries ASeries B

    Early-stage venture firm investing in technical founders solving hard engineering and science problems through the 'Super Evolution' — a non-linear…

    Partners not yet listed
  9. Cathay Innovation
    SeedSeries ASeries BSeries CGrowth

    Multi-stage venture capital firm that goes beyond traditional VC playbook by providing entrepreneurs support of a global ecosystem, connecting…

    Partners not yet listed
  10. Mindset Ventures
    SeedSeries ASeries B

    Early-stage tech investments in the US and Israel, providing access and meaningful connections to help brilliant minds breakthrough.

    Partners not yet listed
  11. Pentech Ventures
    London
    SeedSeries ASeries B

    Supporting ambitious founders to build category defining companies

    Partners not yet listed
  12. Partech
    SeedSeries ASeries BSeries CGrowth
    Partners not yet listed

How this list is built

DryPowder lists every fund with a public profile tagged Series B and Biotech. Funds whose largest published check is $5M or less come first; inside each group, funds with a verified SEC Form D in the last 30 days lead, then profile quality decides. Form D dates come from SEC EDGAR, and SPV and single-deal filings are dropped. Check sizes are what each fund publishes; the median uses only the 1 funds that publish one.

Related investor lists

Other cities

Biotech at other stages

Series B investors by sector

Hubs

How DryPowder compares

Frequently asked questions

How many Series B Biotech VCs are there?

As of October 22, 2026, DryPowder lists 12 Series B Biotech venture funds with a public profile. The first 5 on this page are Speedinvest, DFJ Growth, AME Cloud Ventures, AgFunder and Correlation Ventures.

Which Series B Biotech VCs are actively investing right now?

1 of the 12 filed a verified SEC Form D in the last 90 days, a sign of a new fund being raised: DFJ Growth (Oct 19, 2026). Each filing links to its record on SEC EDGAR.

What check size do Series B Biotech VCs write?

The median published range is $250K–$3M, across the 1 of 12 funds that publish a check size. Published checks on this list run from $250K to $3M.

Where are Series B Biotech VCs based?

Of the 12 Series B Biotech venture funds, 2 are in San Francisco, 1 is in London, 1 is in Palo Alto and 1 is in Toronto. The rest are elsewhere or have no headquarters city on file.

How does DryPowder build this list?

A fund is listed when its public profile is tagged Series B and Biotech. Funds whose largest published check is $5M or less come first; within each group, funds that filed a Form D in the last 30 days lead, then profile quality decides. Form D dates come from SEC EDGAR, with SPVs excluded. Data as of October 22, 2026.

Sources

Updated